Table 2.
PRIMARY OUTCOMES |
Total N of Patients |
CONTINUOUS OUTCOMES | p-Value | ||
---|---|---|---|---|---|
Mean (SD) | Average Differences between groups Intervention – UC) Mean (95% CI) |
||||
Intervention | Usual Care | ||||
Decrease in depression score (SCL-20) from Baseline: | *<0.001 | ||||
6 Month | 183 | 0.72 (0.77) | 0.69 (0.76) | 0.03 (−0.25 to 0.19) | 0.779 |
12 Month | 181 | 1.10 (0.74) | 0.62 (0.78) | 0.48 (−0.70 to –0.25) | < 0.001 |
18 Month | 170 | 1.06 (0.74) | 0.70 (0.81) | 0.36 (−0.60 to –0.12) | 0.004 |
Decrease in functional impairment score (SDS) from Baseline: | *<0.050 | ||||
6 Month | 183 | 1.58 (3.28) | 2.14 (2.60) | −0.56 (−0.30 to 1.43) | 0.200 |
12 Month | 180 | 2.56 (3.10) | 1.95 (2.67) | 0.62 (−1.46 to 0.23) | 0.154 |
18 Month | 169 | 2.56 (3.25) | 2.08 (3.36) | 0.47 (−1.48 to 0.42) | 0.354 |
SD = standard deviation;SCL-20, Hopkins Symptom Checklist-20, range 0–422: SDS, Sheehan Disability Scale (SDS), range 0 – 10.23
Group-by-time interaction: baseline to 18 months.